Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Active Moderate to Severe Rheumatoid Arthritis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01245439
What this trial is testing

RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 65
Large-scale testing (Phase 3)Active Not RecruitingNCT06245408
What this trial is testing

A Safety and Efficacy Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-Severe Symptom State

Who this might be right for
Sjögren's Syndrome (SS)
Amgen 434
Large-scale testing (Phase 3)Study completedNCT04333771
What this trial is testing

Evaluate the Efficacy and Safety of SHR0302 in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Jiangsu HengRui Medicine Co., Ltd. 566
Large-scale testing (Phase 3)Study completedNCT02222493
What this trial is testing

PF-06438179 (Infliximab-Pfizer) and Infliximab in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (REFLECTIONS B537-02).

Who this might be right for
Rheumatoid Arthritis
Pfizer 650
Large-scale testing (Phase 3)Study completedNCT01711359
What this trial is testing

A Study in Participants With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Eli Lilly and Company 588
Large-scale testing (Phase 3)Study completedNCT05814627
What this trial is testing

Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
AbbVie 487
Not applicableStudy completedNCT01558089
What this trial is testing

Good EULAR Response In Patients With Early Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Pfizer 76
Not applicableStudy completedNCT04541810
What this trial is testing

Oral Upadacitinib (RINVOQ) Tablets to Assess Adverse Events and Change in Disease Symptoms in Korean Participants With Moderate to Severe Active Rheumatoid Arthritis, Atopic Dermatitis, Ankylosing Spondylitis or Psoriatic Arthritis

Who this might be right for
Rheumatoid Arthritis (RA)Atopic Dermatitis (AD)Ankylosing Spondylitis (AS)+1 more
AbbVie 2,369
Post-approval studies (Phase 4)Study completedNCT00996203
What this trial is testing

Tocilizumab Added to DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to DMARDs.

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 201
Testing effectiveness (Phase 2)Active Not RecruitingNCT07148414
What this trial is testing

SPY072 in Rheumatic Disease

Who this might be right for
Rheumatoid ArthritisPsoriatic ArthritisAxial Spondyloarthritis+5 more
Spyre Therapeutics, Inc. 285
Testing effectiveness (Phase 2)Study completedNCT04577781
What this trial is testing

A Study Evaluating the Effects of GLPG3970 Given as an Oral Treatment for 6 Weeks in Adults With Moderately to Severely Active Rheumatoid Arthritis and an Inadequate Response to Methotrexate

Who this might be right for
Rheumatoid Arthritis
Lakefront Biotherapeutics NV 28
Post-approval studies (Phase 4)Ended earlyNCT01283971
What this trial is testing

RoActemra/Actemra (Tocilizumab) Versus Adalimumab in Combination With Methotrexate (MTX) in Patients With Moderate to Severe Active Rheumatoid Arthritis And an Inadequate Response to Treatment With Only One Tumor Necrosis Factor (TNF)-Inhibitor

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 96
Post-approval studies (Phase 4)Study completedNCT01578850
What this trial is testing

Study Conducted in Subjects With Rheumatoid Arthritis Who Have Moderate to Severe Disease Activity Despite Methotrexate Therapy With or Without Other Non Biologic Disease Modifying Antirheumatic Drugs (DMARDs)for at Least 12 Weeks Prior to Screening

Who this might be right for
Rheumatoid Arthritis
Pfizer 491
Testing effectiveness (Phase 2)WithdrawnNCT05217472
What this trial is testing

An Efficacy and Safety Study of Injectable Ravagalimab to Assess Change in EULAR Sjogren's Syndrome Disease Activity Index (ESSDAI) in Adult Participants With Moderately to Severely Active Primary Sjogren's Syndrome (pSS)

Who this might be right for
Sjogren's Syndrome (SS)
AbbVie
Testing effectiveness (Phase 2)Study completedNCT00425932
What this trial is testing

Impact of Rituximab on MRI Evidence of Disease Activity in Patients With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Gaylis, Norman B., M.D. 60
Testing effectiveness (Phase 2)Ended earlyNCT02393378
What this trial is testing

Namilumab vs Adalimumab in Participants With Moderate to Severe Early Rheumatoid Arthritis Inadequately Responding to Methotrexate

Who this might be right for
Rheumatoid Arthritis
Takeda 7
Large-scale testing (Phase 3)Study completedNCT00891020
What this trial is testing

Tocilizumab in Patients With Moderate to Severe Active Rheumatoid Arthritis Who Have an Inadequate Response to or Are Unable to Tolerate Biologic and Non-Biologic Disease-modifying Antirheumatic Drugs (DMARDs)

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 886
Testing effectiveness (Phase 2)Study completedNCT00243412
What this trial is testing

The Safety and Efficacy of Rituximab in Patients With Moderate to Severe Rheumatoid Arthritis Receiving Methotrexate

Who this might be right for
Rheumatoid Arthritis
Genentech, Inc. 42
Large-scale testing (Phase 3)Study completedNCT02706847
What this trial is testing

Compare Upadacitinib (ABT-494) to Placebo in Adults With Rheumatoid Arthritis on Stable Dose of Conventional Synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) With an Inadequate Response or Intolerance to Biologic DMARDs

Who this might be right for
Rheumatoid Arthritis
AbbVie 499
Testing effectiveness (Phase 2)Ended earlyNCT07100938
What this trial is testing

A Study Investigating the Efficacy and Safety of BGB-45035 Versus Placebo in Adults With Moderate to Severe Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
BeiGene 49
Next Page